Clinical Trial Update: Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study [Phase 2]

View source ↗

Summary

Phase II proof-of-concept study evaluating cannabidiol (CBD) for managing withdrawal in cannabis use disorder; status of the trial is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: The University of New South Wales | Conditions: Cannabis Use Disorder | Phase 2 | Status: UNKNOWN